De novo hepatocellular carcinoma 18 years after liver and small bowel transplantation in a one-year-old pediatric patient.
hepatic mass
long-term outcome
short gut syndrome
Journal
Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
09
05
2020
revised:
30
06
2020
accepted:
02
07
2020
pubmed:
28
8
2020
medline:
5
1
2022
entrez:
27
8
2020
Statut:
ppublish
Résumé
De novo HCC following transplantation in a child is a rare occurrence. Even within the adult liver transplantation population, there are a limited number of published cases. In this report, we present a case of de novo HCC found in a child, post-multivisceral transplantation. A 19-year-old boy, at the age of one, received liver and small bowel transplantation due to short gut syndrome secondary to midgut volvulus and total parenteral nutrition-associated liver disease. Eighteen years later, he was found to have a large mass involving the right hepatic dome consistent with HCC. To the best of our knowledge, this is the second reported case after gut transplantation and the third case post-liver transplantation in the pediatric population.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13820Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358-380.
Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):3980-3999.
Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15(2):443-462.
Kelly Deirdre, Sharif Khalid, Brown Rachel M, Morland Bruce. Hepatocellular carcinoma in children. Clin Liver Dis. 2015;19(2):433-447.
Trevisani F, Garuti F, Cucchetti A, et al. De novo hepatocellular carcinoma of liver allograft: a neglected issue. Cancer Lett. 2015;357(1):47-54.
Ramadori Giuliano, Bosio Patrizia, Moriconi Federico, Malik Ihtzaz A. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy. BMC Cancer. 2018;18(1):2.
Tamè Mariarosa, Calvanese Claudio, Cucchetti Alessandro, Gruppioni Elisa, Colecchia Antonio, Bazzoli Franco. The onset of de novo hepatocellular carcinoma after liver transplantation can be both of donor and recipient origin. a case report. J Gastrointestin Liver Dis. 2020;24(3):387-389.
Navarro Burgos JB, Lee K-W, Shin YC, et al. Inexplicable outcome of early appearance of hepatocellular carcinoma in the allograft after deceased donor liver transplantation: a case report. Transpl Proc. 2015;47(10):3012-3015.
Saab S, Zhou K, Chang EK, Busuttil RW. De novo hepatocellular carcinoma after liver transplantation. J Clin Transl Hepatology. 2015;3(4):284-287.
Allaire M, Allaire M, Sérée O, et al. De novo primary liver cancer after liver transplantation: a french national study on 15803 patients. Exp Clin Transplant. 2018;16:779-780.
Torres-Landa S, Munoz-Abraham AS, Fortune BE, et al. De-Novo hepatocellular carcinoma after pediatric living donor liver transplantation. World J Hepatol. 2017;9(36):1361-1366.
Tran P, Zhou S, Wang L, et al. De novo hepatocellular carcinoma post-multivisceral transplantation in a child. Pediatr Transplant. 2017;21(7):9.
Manzia TM, Angelico R, Gazia C, et al. De novo malignancies after liver transplantation: the effect of immunosuppressionn-personal data and review of literature. World J Gastroenterol. 2019;25(35):5356-5375.
Yanik EL, Smith JM, Shiels MS, et al. Cancer risk after pediatric solid organ transplantation. Pediatrics. 2017;139(5):e20163893.
Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation. 2009;88(7):926-934.
Abu-Elmagd KM, Zak M, Stamos JM, et al. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004;77(11):1719-1725.
Fischer SE. Recurrent and de novo malignancies following liver transplantation. Diagn Histopathol. 2012;18(7):290-296.
Yu S-B, Kim H-Y, Eo H, et al. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma. World J Surg. 2005;30(1):43-50.
Angelico R, Grimaldi C, Saffioti MC, Castellano A, Spada M. Hepatocellular carcinoma in children: hepatic resection and liver transplantation. Transl Gastroenterol Hepatol. 2018;3:59.
Baumann U, Adam R, Duvoux C, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transplant. 2018;24(2):246-255.
Lau CSM, Mahendraraj K, Chamberlain RS. Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the surveillance, epidemiology, and end result (SEER) database (1973-2011). HPB Surg. 2015;2015:1-10.
Czauderna P. Adult type vs. childhood hepatocellular carcinoma? Are they the same or different lesions? biology, natural history, prognosis, and treatment. Med Pediatr Oncol. 2002;39(5):519-523.
Mcateer JP, Goldin AB, Healey PJ, Gow KW. Surgical treatment of primary liver tumors in children: outcomes analysis of resection and transplantation in the SEER database. Pediatr Transplant. 2013;17(8):744-750.
Romano F, Stroppa P, Bravi M, et al. Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma. Pediatr Transplant. 2011;15:573-579.
Murawski M, Weeda VB, Maibach R, et al. Hepatocellular carcinoma in children: does modified platinum- and doxorubicin-based chemotherapy increase tumor resectability and change outcome? lessons learned from the SIOPEL 2 and 3 studies. J Clin Oncol. 2016;34(10):1050-1056.
Harris PS, Hansen RM, Gray ME, et al. Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol. 2019;25(13):1550-1559.